José Carrillo, M.D.
Hoag Brain Tumor Clinic

José Carrillo, M.D., is a board-certified neurologist and neuro-oncologist specializing in the diagnosis and treatment of primary and secondary brain tumors, including glioblastoma multiforme, primary CNS lymphoma, meningioma, and brain metastases, as well as the neurologic complications of cancer.

Dr. Carrillo is involved in the enrollment of patients into several clinical trials. Dedicated to advancing medicine, Dr. Carrillo is a strong proponent of leading-edge research in the diagnosis, treatment and prevention of all types of CNS tumors, including metastatic brain and spine tumors, primary malignant brain and spinal cord tumors, primary benign or low‐grade brain or spine tumors, and skull base and pituitary tumors. His particular research interests involve neuroimaging brain tumor features and molecular markers pertaining to treatment and survival. Other areas of interest include glioblastoma, leptomeningeal metastases, metastatic brain cancers, immunotherapy and paraneoplastic syndromes.

Dr. Carrillo is an Associate Professor of Neurology at the John Wayne Cancer Institute at Providence Saint John’s Health Center and has been recognized by Coast magazine as a “Physician of Excellence,” and by L.A. Magazine as a “Southern California Super Doctor.”

Dr. Carrillo completed his medical degree at Dartmouth Medical School in Hanover, NH. He did his residency in Neurology at Harbor-UCLA in Torrance, CA and fellowship in Neuro-Oncology at UCLA.

Santosh Kesari, M.D., Ph.D.
Neuroscientist and Neuro-Oncologist
Hoag Brain Tumor Clinic

Santosh Kesari, M.D., Ph.D., is a board-certified neurologist and neuro-oncologist. He is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd. An internationally recognized scientist and clinician, he was also awarded an Innovation Award by the San Diego Business Journal and recently the 2019 Duke Special Service Award from the John Wayne Cancer Institute Auxiliary.

Dr. Kesari has had a long-standing interest in cancer stem cells and studies their role in the formation of brain tumors and resistance to treatment. He believes that in order to cure patients with brain tumors we first need to gain a better molecular and biological understanding of the disease. A physician/scientist, Kesari harnesses his experience in surgery, chemotherapy, immunotherapy, radiation therapy and novel devices to help develop precision therapeutic strategies that will advance medicine to a new stage in the battle against brain tumors. Additionally Dr. Kesari has focused on developing novel drugs and using stem cells for repairing neurological disorders including dementias, traumatic brain injury, stroke and neuropathies.

Dr. Kesari graduated from University of Pennsylvania, School of Arts and Sciences and earned a Ph.D. in molecular biology and an MD from the University of Pennsylvania, School of Medicine. He completed his residency in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston.